Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek Wong

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Blood|January 16, 2010
The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myelomaG Wei Xu, Mohsin Ali, Tabitha E Wood, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|December 1, 2018
Sensitivity, specificity, and reliability of the Get Active Questionnaire for identifying children with medically necessary special considerations for physical activityPatricia E Longmuir, Julia Jackson, Emily Ertel, et al.
Journal of the National Cancer Institute|May 3, 2024
Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalenceMinjie Luo, Derek Wong, Kristin Zelley, et al.
Molecular Genetics and Metabolism|July 22, 2019
Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patientsGeorge A Diaz, Andreas Schulze, Nicola Longo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor ProgressionStephanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield, et al.
Translational Science of Rare Diseases|January 8, 2019
Conducting an investigator-initiated randomized double-blinded intervention trial in acute decompensation of inborn errors of metabolism: Lessons from the N-Carbamylglutamate ConsortiumNicholas Ah Mew, Avital Cnaan, Robert McCarter, et al.
The New England Journal of Medicine|November 9, 2022
In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's DiseaseJennifer L Cohen, Pranesh Chakraborty, Karen Fung-Kee-Fung, et al.
Cancer Discovery|February 23, 2024
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid TumorsEric Y Stutheit-Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, et al.
Iscience|March 1, 2019
HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor SuppressionNikita Patel, Juehong Wang, Kumiko Shiozawa, et al.
NPJ Genomic Medicine|May 9, 2025
Mosaic X-linked adrenoleukodystrophy in males identified by newborn screening and next-generation sequencingAlexandra C Keefe, Dana M Jensen, Meranda M Pham, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Blood|January 16, 2010
The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myelomaG Wei Xu, Mohsin Ali, Tabitha E Wood, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|December 1, 2018
Sensitivity, specificity, and reliability of the Get Active Questionnaire for identifying children with medically necessary special considerations for physical activityPatricia E Longmuir, Julia Jackson, Emily Ertel, et al.
Journal of the National Cancer Institute|May 3, 2024
Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalenceMinjie Luo, Derek Wong, Kristin Zelley, et al.
Molecular Genetics and Metabolism|July 22, 2019
Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patientsGeorge A Diaz, Andreas Schulze, Nicola Longo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor ProgressionStephanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield, et al.
Translational Science of Rare Diseases|January 8, 2019
Conducting an investigator-initiated randomized double-blinded intervention trial in acute decompensation of inborn errors of metabolism: Lessons from the N-Carbamylglutamate ConsortiumNicholas Ah Mew, Avital Cnaan, Robert McCarter, et al.
The New England Journal of Medicine|November 9, 2022
In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's DiseaseJennifer L Cohen, Pranesh Chakraborty, Karen Fung-Kee-Fung, et al.
Cancer Discovery|February 23, 2024
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid TumorsEric Y Stutheit-Zhao, Enrique Sanz-Garcia, Zhihui Amy Liu, et al.
Iscience|March 1, 2019
HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor SuppressionNikita Patel, Juehong Wang, Kumiko Shiozawa, et al.
NPJ Genomic Medicine|May 9, 2025
Mosaic X-linked adrenoleukodystrophy in males identified by newborn screening and next-generation sequencingAlexandra C Keefe, Dana M Jensen, Meranda M Pham, et al.
Pageof 8